Hemenway Trust Hemenway Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $24.7M | Buy |
55,515
+1,191
| +2% | +$530K | 1.91% | 23 |
|
2025
Q1 | $26.3M | Buy |
54,324
+4,911
| +10% | +$2.38M | 2.14% | 23 |
|
2024
Q4 | $19.9M | Buy |
49,413
+9,294
| +23% | +$3.74M | 1.61% | 26 |
|
2024
Q3 | $18.7M | Buy |
40,119
+11,682
| +41% | +$5.43M | 1.48% | 28 |
|
2024
Q2 | $13.3M | Buy |
28,437
+12,919
| +83% | +$6.06M | 1.14% | 30 |
|
2024
Q1 | $6.49M | Buy |
15,518
+10,835
| +231% | +$4.53M | 0.56% | 35 |
|
2023
Q4 | $1.91M | Buy |
4,683
+917
| +24% | +$373K | 0.18% | 46 |
|
2023
Q3 | $1.31M | Buy |
3,766
+40
| +1% | +$13.9K | 0.14% | 63 |
|
2023
Q2 | $1.31M | Buy |
3,726
+185
| +5% | +$65.1K | 0.13% | 63 |
|
2023
Q1 | $1.12M | Sell |
3,541
-5
| -0.1% | -$1.58K | 0.12% | 64 |
|
2022
Q4 | $1.02M | Buy |
3,546
+125
| +4% | +$36.1K | 0.11% | 72 |
|
2022
Q3 | $991K | Buy |
3,421
+890
| +35% | +$258K | 0.12% | 70 |
|
2022
Q2 | $713K | Buy |
2,531
+1,110
| +78% | +$313K | 0.08% | 75 |
|
2022
Q1 | $371K | Hold |
1,421
| – | – | 0.04% | 103 |
|
2021
Q4 | $312K | Hold |
1,421
| – | – | 0.03% | 110 |
|
2021
Q3 | $258K | Buy |
+1,421
| New | +$258K | 0.03% | 123 |
|